Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Levorphanol Tartrate Anhydrous
2. Levorphan Tartrate
3. Levorphanol Bitartrate
4. Wcb1i20f1k
5. 125-72-4
6. D-(-)-levorphanol Tartrate
7. Morphinan-3-ol, 17-methyl-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
8. L-3-hydroxy-n-methylmorphinan Tartrate
9. Ro 1-5431/7
10. Levorphanol Hydrogen Tartrate
11. Nih 4590
12. Einecs 204-753-8
13. Nsc 91012
14. Unii-wcb1i20f1k
15. Nsc-91012
16. Levorphanol L-tartrate
17. Morphinan-3-ol, 17-methyl-, Tartrate (1:1) (salt), (-)-
18. Morphinan-6-ol, N-methyl-, Tartrate (1:1) (salt), Stereoisomer
19. 2h-10,4a-iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, Tartrate
20. Schembl4336924
21. Dtxsid30924987
22. Pdsp2_001546
23. Levorphanol Tartrate [who-dd]
24. Morphinan-3-ol, 17-methyl-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)
25. Q27292556
26. 17-methylmorphinan-3-ol, Tartrate (1:1) (salt)
27. 17-methylmorphinan-3-ol (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 407.5 g/mol |
---|---|
Molecular Formula | C21H29NO7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 3 |
Exact Mass | 407.19440226 g/mol |
Monoisotopic Mass | 407.19440226 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 491 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levorphanol tartrate |
Drug Label | Levo-Dromoran (levorphanol tartrate) is a potent opioid analgesic with empirical formula C17H23NOC4H6O62H2O and molecular weight 443.5. Each mg of levorphanol tartrate is equivalent to 0.58 mg levorphanol base. Chemically levorphanol is levo-3-... |
Active Ingredient | Levorphanol tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Roxane |
2 of 2 | |
---|---|
Drug Name | Levorphanol tartrate |
Drug Label | Levo-Dromoran (levorphanol tartrate) is a potent opioid analgesic with empirical formula C17H23NOC4H6O62H2O and molecular weight 443.5. Each mg of levorphanol tartrate is equivalent to 0.58 mg levorphanol base. Chemically levorphanol is levo-3-... |
Active Ingredient | Levorphanol tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Roxane |
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-07
Pay. Date : 2019-01-28
DMF Number : 33224
Submission : 2018-12-31
Status : Active
Type : II
NDC Package Code : 58159-061
Start Marketing Date : 2019-11-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-08-16
Pay. Date : 2021-06-10
DMF Number : 35977
Submission : 2021-05-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-05-17
Pay. Date : 2023-04-03
DMF Number : 34304
Submission : 2020-01-17
Status : Active
Type : II
NDC Package Code : 50683-0514
Start Marketing Date : 2019-12-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-11-21
Pay. Date : 2017-09-08
DMF Number : 18823
Submission : 2005-09-29
Status : Active
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20747
Submission : 2007-08-02
Status : Active
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7625
Submission : 1988-08-09
Status : Inactive
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9968
Submission : 1992-11-13
Status : Inactive
Type : II
NDC Package Code : 0406-0545
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3726
Submission : 1980-02-15
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?